drugset / Trial / NCT04089072
Methylene Blue as a Third-line Vasopressor in Septic Shock
RandomizedParallel-groupOpen-labelTreatment
Summary
A randomized, prospective study comparing ProvayBlue® to standard care with multiple sympathomimetic vasopressors.
Timeline
- Start
- 2019-12-01
- Primary completion
- 2024-10-01
- Completion
- 2024-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylene Blue | Diagnostic / imaging agent | 2 mg/kg | — |
| Subject | Phenylephrine | Small molecule | 0.05 mg | — |